Adam Ogden

700 total citations
13 papers, 346 citations indexed

About

Adam Ogden is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Adam Ogden has authored 13 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Adam Ogden's work include Phosphodiesterase function and regulation (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Adam Ogden is often cited by papers focused on Phosphodiesterase function and regulation (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Adam Ogden collaborates with scholars based in United States, United Kingdom and Japan. Adam Ogden's co-authors include M. Guillaume Wientjes, J Grosset, Tong Zhu, Eric L. Nuermberger, Kathy N. Williams, Sandeep Tyagi, C. Kendall Stover, Steven J. Brickner, Rokeya Tasneen and John C. Byrd and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Adam Ogden

13 papers receiving 328 citations

Peers

Countries citing papers authored by Adam Ogden

Since Specialization

Citations

This map shows the geographic impact of Adam Ogden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Ogden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Ogden more than expected).

Fields of papers citing papers by Adam Ogden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Ogden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Ogden. The network helps show where Adam Ogden may publish in the future.

Co-authorship network of co-authors of Adam Ogden

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Ogden. A scholar is included among the top collaborators of Adam Ogden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Ogden. Adam Ogden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes 2023 ·The Journal of Clinical Pharmacology ·(unknown), Donal Gorman, (unknown), Yizhong Zhang, Adam Ogden, (unknown), Aditi R. Saxena	4
2	Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA_A‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers 2021 ·Clinical Pharmacology in Drug Development ·Rachel Gurrell, Mark Whitlock, Hua Wei, Zhongzhou Shen, Adam Ogden	6
3	A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia 2019 ·Journal of Clinical Psychopharmacology ·Nicholas DeMartinis, (unknown), Eve H. Pickering, Christopher J. Schmidt, Lev Gertsik, David P. Walling, Adam Ogden	20
4	Photosensitive epilepsy 2019 ·Neurology ·Rachel Gurrell, Donal Gorman, Mark Whitlock, Adam Ogden, David S. Reynolds, Bree DiVentura, Bassel Abou‐Khalil, Michael Gelfand, John R. Pollard, R. Edward Hogan, Gregory L. Krauss, Michael R. Sperling, Blanca Vázquez, Robert Wechsler, Daniel Friedman, Richard P. Butt, Jacqueline A. French	30
5	J06 A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-02545920 in huntington disease (amaryllis) 2018 ·Clinical Therapeutics ·Marielle Delnomdedieu, Ye Tan, Adam Ogden, Zdenek Berger, Ralf Reilmann	7
6	In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects 2017 ·Neuropharmacology ·Marielle Delnomdedieu, Anton Forsberg, Adam Ogden, Patrik Fazio, Ching‐Ray Yu, Per Stenkrona, Sridhar Duvvuri, William David, Nabil Al‐Tawil, Ottavio V. Vitolo, Nahid Amini, Sangram Nag, Christer Halldin, Andrea Varrone	22
7	First-in-Human Assessment of the Novel PDE2A PET Radiotracer ¹⁸F-PF-05270430 2016 ·Journal of Nuclear Medicine ·Mika Naganawa, Rikki N. Waterhouse, Nabeel Nabulsi, Shu-fei Lin, David Labaree, Jim Ropchan, Sanela Tarabar, Nicholas DeMartinis, Adam Ogden, Anindita Banerjee, Yiyun Huang, Richard E. Carson	24
8	Prediction of Efficacy of Vabicaserin, a 5‐HT_2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model 2014 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Adam Ogden, (unknown), Äthan Spiros, Patrick J. Roberts, Hugo Geerts	29
9	Evaluation of Pharmacokinetic/Pharmacodynamic Relationships of PD-0162819, a Biotin Carboxylase Inhibitor Representing a New Class of Antibacterial Compounds, Using In Vitro Infection Models 2011 ·Antimicrobial Agents and Chemotherapy ·Adam Ogden, Michael Kuhn, (unknown), (unknown), (unknown), Tong Zhu, Deqing Xiao, J. Richard Miller, Debra Hanna	3
10	Addition of PNU-100480 to First-Line Drugs Shortens the Time Needed to Cure Murine Tuberculosis 2009 ·American Journal of Respiratory and Critical Care Medicine ·Kathy N. Williams, Steven J. Brickner, C. Kendall Stover, Tong Zhu, Adam Ogden, Rokeya Tasneen, Sandeep Tyagi, J Grosset, Eric L. Nuermberger	95
11	Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease 2005 ·Journal of Clinical Oncology ·Javier Bolaños‐Meade, David A. Jacobsohn, Jeffrey Margolis, Adam Ogden, M. Guillaume Wientjes, John C. Byrd, David Lucas, Viki Anders, Michele Phelps, Michael R. Grever, Georgia B. Vogelsang	88
12	Suramin as a Chemosensitizer: Oral Pharmacokinetics in Rats 2004 ·Pharmaceutical Research ·Adam Ogden, M. Guillaume Wientjes, Jessie L.‐S. Au	8
13	Solid-phase synthesis of functionalized 1,2,4-triazin-6-ones 2002 ·Tetrahedron Letters ·Benjamin E. Blass, (unknown), (unknown), Song Liu, Adam Ogden, David E. Portlock, Anil Srivastava	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact